NCT03842501

Effects of the GOLO Weight Management Program With and Without Release Supplement on Weight and Metabolic Parameters in Subjects With Obesity

A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effects of the GOLO Weight Management Program With and Without Release Supplement on Weight and Metabolic Parameters in Subjects With Obesity

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 68 (actual)
• Sponsor: Golo · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Accepted

Summary

This randomized, double-blind placebo-controlled study was intended to measure the effects of the GWMP with Release supplement versus GWMP with placebo supplement in a representative group of obese subjects with or without diabetes at one outpatient medical practice.

Conditions

• Obesity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Release Supplement	Calorie reduced diet plus Release supplement
DIETARY_SUPPLEMENT	Placebo	Calorie reduced diet plus Placebo

Timeline

• Start date: 2018-07-01
• Primary completion: 2018-12-24
• Completion: 2018-12-24
• First posted: 2019-02-15
• Last updated: 2019-02-15

Locations

1 site across 1 country: United States